Molecular targeted treatment and radiation therapy for rectal cancer (Q37511793)

20 August 2017

0 references

1 reference

title

Molecular targeted treatment and radiation therapy for rectal cancer (English)

1 reference

adaptive radiation therapy

20 August 2017

main subject

0 references

5

Claus Rödel

1 reference

20 August 2017

Friederike Marquardt

1

1 reference

20 August 2017

Franz Rödel

series ordinal

2

1 reference

20 August 2017

Gianni Capalbo

series ordinal

3

1 reference

20 August 2017

Christian Weiss

series ordinal

4

1 reference

20 August 2017

publication date

9 June 2009

1 reference

Strahlentherapie und Onkologie

20 August 2017

published in

1 reference

20 August 2017

volume

185

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

371-378

1 reference

Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00066-009-1936-5

Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00066-009-1936-5

Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00066-009-1936-5

Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00066-009-1936-5

Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00066-009-1936-5

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

21 January 2018

1 reference

12 December 2020

Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer

1 reference

12 December 2020

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.

1 reference

12 December 2020

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy

1 reference

12 December 2020

Reduced Survival of Rectal Cancer Patients With Increased Tumor Epidermal Growth Factor Receptor Levels

1 reference

12 December 2020

Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors.

1 reference

12 December 2020

Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro

1 reference

12 December 2020

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

1 reference

12 December 2020

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

1 reference

12 December 2020

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

1 reference

12 December 2020

Adaptive RT in rectal cancer: superior to 3D-CRT? A simple question, a complex answer.

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

12 December 2020

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer

1 reference

12 December 2020

Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy

1 reference

12 December 2020

Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results

1 reference

12 December 2020

Irradiation with and without Razoxane in the Treatment of Incompletely Resected or Inoperable Recurrent Rectal Cancer

1 reference

12 December 2020

In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody

1 reference

12 December 2020

The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis

1 reference

12 December 2020

Integration of novel agents into combined-modality treatment for rectal cancer patients

1 reference

12 December 2020

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

1 reference

12 December 2020

Prognostic Significance of Vascular Endothelial Growth Factor and Cyclooxygenase-2 in Patients with Rectal Cancer Treated with Preoperative Radiotherapy

1 reference

12 December 2020

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

1 reference

12 December 2020

Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation

1 reference

12 December 2020

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

12 December 2020

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

1 reference

12 December 2020

Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer

1 reference

12 December 2020

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

1 reference

12 December 2020

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation

1 reference

12 December 2020

Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer

1 reference

12 December 2020

Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

1 reference

12 December 2020

10.1007/S00066-009-1936-5

Identifiers

DOI

1 reference

20 August 2017

1 reference